Small RNAs in the peripheral blood discriminate metastasized from non-metastasized seminoma

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Ruf, Christian G ^a,b   Dinger, Daniela ^a   Port, Matthias ^b,d   Schmelz, Hans Ulrich ^b,c   Wagner, Walter ^a   Matthies, Cord ^a   Müller Myhsok, Bertram ^e   Meineke, Viktor ^b   Abend, Michael ^b  

^a Bundeswehrkrankenhaus Hamburg   (Germany)

^b Bundeswehr Institute of Radiobiology   (Germany)

^c BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Blood; Gene expression; Metastasized seminoma; MicroRNA; Next generation sequencing; Risk factor; Small RNA; Testis tumour; Tumour marker

Indexed keywords

ANTINEOPLASTIC AGENT; RNA; SMALL RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; GENE EXPRESSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; RNA PROCESSING; RNA SEQUENCE; SEMINOMA; SUPPORT VECTOR MACHINE; TUMOR GENE; UNIVARIATE ANALYSIS;

ADULT; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897475208     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-47     Document Type: Article

References (21)

1. Ruf CG, Isbarn H, Wagner W, Fisch M, Matthies C, Dieckmann KP. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing(). Urol Oncol 2014, 32(1):33. e1-6. doi:10.1016/j.urolonc.2012.12.002. Epub 2013 Feb 6.
2. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Stahl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008, 53:478-496. 10.1016/j.eururo.2007.12.024, 18191324.
3. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. Actas Urol Esp 2012, 36:127-145.
4. Ruf CG, Khalili-Harbi N, Sachs S, Isbarn H, Wagner W, Matthies C, Meineke V, Fisch M, Chun FK, Abend M. The search for biomarkers of metastatic seminoma. J Urol 2013, 190(3):1046-1051. doi:10.1016/j.juro.2013.04.022. Epub 2013 Apr 10, 10.1016/j.juro.2013.04.022, 23583226.
5. Kollmannsberger C, Tyldesley S, Moore C, Chi KN, Murray N, Daneshmand S, Black P, Duncan G, Hayes-Lattin B, Nichols C. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. Ann Oncol 2011, 22:808-814. 10.1093/annonc/mdq466, 20926549.
6. Dieckmann KP, Spiekermann M, Balks T, Flor I, Loning T, Bullerdiek J, Belge G. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 2012, 107:1754-1760. 10.1038/bjc.2012.469, 3493876, 23059743.
7. Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, van der Spek PJ, de Alarcon P, Looijenga LH. High-throughput microRNAome analysis in human germ cell tumours. J Pathol 2007, 213:319-328. 10.1002/path.2230, 17893849.
8. Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N, . Children's Cancer and Leukaemia Group Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 2010, 70:2911-2923. 10.1158/0008-5472.CAN-09-3301, 3000593, 20332240, Children's Cancer and Leukaemia Group.
9. Port M, Glaesener S, Ruf C, Riecke A, Bokemeyer C, Meineke V, Honecker F, Abend M. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Mol Cancer 2011, 10:52. 10.1186/1476-4598-10-52, 3120796, 21575166.
10. Liu X, Yu J, Jiang L, Wang A, Shi F, Ye H, Zhou X. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 2009, 6:131-139. 2890246, 19487542.
11. Profumo V, Gandellini P. MicroRNAs: cobblestones on the road to cancer metastasis. Crit Rev Oncog 2013, 18:341-355. 10.1615/CritRevOncog.2013007182, 23614620.
12. Ruf CG, Nastaly P, Becker P, Isbarn H, Honecker F, Pantel K, Riethdorf S, Hoeppner D, Fisch M, Wagner W, Ahyai S. Circulating tumor cells can be detected in patients with testicular germ cell tumors. J Urol 2013, 189:e289.
13. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007, 315:1576-1579. 10.1126/science.1137999, 2556962, 17322030.
14. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647. 10.1016/j.cell.2005.01.014, 15766527.
15. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009, 139:693-706. 10.1016/j.cell.2009.10.014, 2783826, 19878981.
16. Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Sacca M, Memeo L, Colarossi C, Francescangeli F, Biffoni M, Collura D, Giacobbe A, D'Urso L, Falchi M, Venneri MA, Muto G, De Maria R, Bonci D. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 2011, 30:4231-4242. 10.1038/onc.2011.140, 21532615.
17. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A 2010, 107:8231-8236. 10.1073/pnas.1002080107, 2889540, 20406904.
18. Ruf CG, Linbecker M, Port M, Riecke A, Schmelz HU, Wagner W, Meineke V, Abend M. Predicting metastasized seminoma using gene expression. BJU Int 2012, 110:E14-E20. 10.1111/j.1464-410X.2011.10778.x, 22243760.
19. Port M, Wang Y, Schmelz HU, Pottek T, Meineke V, Ruf C, Abend M. A gene signature of primary tumor identifies metastasized seminoma. Urol Oncol 2011, 29:764-773. 10.1016/j.urolonc.2009.08.008, 19945308.
20. Port M, Seidl C, Ruf CG, Riecke A, Meineke V, Abend M. Reliable and sample saving gene expression analysis approach for diagnostic tool development. Health Phys 2012, 103:159-168.
21. Baggerly KA, Deng L, Morris JS, Aldaz CM. Overdispersed logistic regression for SAGE: modelling multiple groups and covariates. BMC Bioinform 2004, 5:144.